How to Verify a Research Peptide Certificate of Analysis (COA)

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is a document issued by an analytical laboratory confirming the identity and purity of a specific batch of research compound. For research peptides, the COA is the primary quality document — it answers the question: "Is this what it says it is, and is it as pure as claimed?"

When a research supplier publishes batch-level COA documentation, it means their records are traceable: each batch can be matched to a specific lot number, and that lot has a documented analytical result from a laboratory that tested it independently.

What a COA Should Include

A legitimate research-grade COA from an independent laboratory includes:

1. Product name and CAS number — confirms compound identity

2. Batch or lot number — links the document to specific production units

3. Testing laboratory name — ideally with an ISO or accreditation number

4. Date of analysis — should be within the last 12–24 months for current stock

5. HPLC purity result — the percentage of the sample attributable to the target peptide

6. Mass spectrometry result — observed molecular weight vs. theoretical weight

Some COAs also include:

• Net peptide content (actual peptide mass after accounting for water and salt counterions)
• Moisture content (Karl Fischer titration)
• Residual solvent data
• Endotoxin or sterility data (more common in materials held to pharmaceutical-grade analytical standards)

How to Read HPLC Purity

High-Performance Liquid Chromatography (HPLC) separates a sample into its chemical components and measures what percentage of the total peak area is attributable to the target peptide.

• ≥99% purity means at least 99% of the UV-detected area corresponds to the target peptide peak
• ≥95% purity is the broadly accepted research-grade minimum; adequate for most in vitro studies
• Impurities typically represent truncated synthesis sequences, oxidized side-chain variants, or retained reagents — not unknown contaminants

What to look for: The HPLC report shows a chromatogram — a graph of detector signal over time. The target peptide peak should dominate the area. The purity percentage is calculated from the ratio of the main peak area to total detected area. A single dominant peak with minimal noise is expected for a well-synthesized research compound. For a detailed walkthrough of chromatogram anatomy, peak symmetry, impurity peaks, and baseline evaluation, see How to Read HPLC Purity Data.

Phase 1 Peptides provides batch-level HPLC documentation and COA access so researchers can review analytical testing data before ordering. COA records are available on the Lab Tests page and on each product page.

How to Read Mass Spectrometry (MS)

Mass spectrometry — reported on a COA as LC-MS data — measures the molecular weight of the compound. Two values matter:

• Observed MW — the molecular weight the spectrometer detected
• Theoretical MW — the expected weight for the stated amino acid sequence

A match within ±1 dalton confirms the compound has the correct molecular structure. A significant mismatch is a red flag indicating a wrong compound or synthesis error.

For complex peptides (modified sequences, fatty acid chains, large macrocycles), the MS analysis may show the [M+H]+ or [M+2H]2+ charge state — the molecular ion plus proton adducts. Mass spec software converts this to the neutral molecular weight.

Red Flags in a COA

Treat these as warning signs:

• COA issued by the same company selling the compound (in-house testing without independent verification)
• No laboratory name or no accreditation number on the document
• Batch number on COA does not match the batch number in the product listing
• Date of analysis older than 24 months
• Missing molecular weight data (purity reported but identity not confirmed)
• Purity stated as "≥99%" with no accompanying chromatogram or raw data
• PDF showing visible image compression artifacts or signs of document editing

Note on chromatogram format: Some suppliers show HPLC chromatograms at small scale. A well-synthesized research peptide should produce a flat baseline with one dominant, sharp peak. Multiple peaks of comparable height indicate significant impurity content.

In-House vs. Independent COAs

Type

Description

Limitation

In-house COA	Testing performed by the supplier's own lab	No independent verification; conflict of interest
Third-party COA	Testing performed by a separate, accredited laboratory	Higher credibility; lab has no financial interest in the result

Third-party COAs from ISO-registered or externally accredited laboratories represent the analytical standard for research compounds. The testing laboratory faces reputational and regulatory consequences for falsified results, providing an independent check that internal testing cannot.

Phase 1 Peptides uses third-party laboratory testing for batch analytical documentation. Certificate of Analysis records are made available on product pages. Researchers with questions about specific batch documentation can contact support@phase1-peptides.com.

Verifying Batch Documentation

Batch-level documentation allows researchers to match a specific lot of compound to its corresponding analytical record. To verify documentation for a given batch:

• Locate the batch or lot identifier from the product label or order documentation
• Navigate to the product page or the Lab Tests section of the website to access available COA records
• Confirm the lot or batch identifier on the COA corresponds to the material in question
• Verify the compound name and molecular weight on the COA match the expected compound structure

Researchers reviewing documentation for specific batches who cannot locate a record can contact support@phase1-peptides.com with their order reference.

Why Batch-Level Documentation Matters

A product-level COA — one document covering all batches of a compound — does not provide lot-specific verification. Peptide purity and composition can vary between synthesis runs. A COA from a prior lot does not confirm the analytical profile of a different production run.

Batch-level documentation means:

• Each production run is independently tested before release
• Batches that do not meet analytical specifications are not dispatched
• Researchers can cross-reference experimental data against the documented analytical profile of the specific lot used

This traceability standard is the baseline for serious research documentation practice.

What should a researcher verify first when reviewing a research peptide COA?

Start by confirming the batch or lot number on the COA matches the vial label — this ensures the analytical data applies to the specific material you received. Then verify the HPLC purity meets the stated specification, confirm the observed molecular weight from mass spectrometry matches the theoretical value within ±1 dalton, and check the date of analysis is recent (within the last 24 months).

What is the difference between an in-house and a third-party COA?

A third-party COA is issued by an independent laboratory with no financial relationship with the product supplier. An in-house COA is generated by the supplier's own lab. Third-party COAs carry higher credibility because the testing laboratory has no commercial incentive to report favorable results. Phase 1 Peptides publishes third-party COAs per batch so researchers can review independently generated analytical data.

What are red flags that indicate a potentially unreliable COA?

Key red flags include: no independent laboratory name or accreditation number; a batch number that does not match the product listing; a date of analysis older than 24 months; HPLC purity stated without a supporting chromatogram; mass spectrometry data absent or showing a significant molecular weight mismatch; and visible document editing artifacts or image compression. Any of these issues warrants verification before using the material in research.

Why is the date of analysis relevant when evaluating a COA?

The date confirms when the batch was tested. A date beyond 24 months may indicate aged stock whose current condition has not been recently verified. It also provides context for evaluating the analytical methods used — more recent analyses from accredited labs reflect current methodology standards. Batch-level COA documentation with recent dates is the baseline expectation for serious research procurement.

Related Quality Resources

• Understanding Certificates of Analysis — field-by-field walkthrough of every COA section
• How to Read HPLC Purity Data — chromatogram anatomy, peak area, and impurity interpretation
• Lab Testing & Verified Purity — HPLC and mass spectrometry methodology overview
• Peptide Concentration Calculations — converting net peptide content into accurate stock concentrations
• TFA Content & Salt Form Interpretation — understanding counterions and their effect on net peptide content
• Lyophilization & Freeze-Drying — why peptides are supplied lyophilized and stability implications
• Storage & Handling Best Practices — cold-chain requirements, reconstitution protocol, and handling errors to avoid
• LC-MS Identity Confirmation — deep dive on reading m/z values, charge states, and mass spectrometry identity results on a COA
• HPLC vs LC-MS: A Researcher's Comparison — how HPLC purity and LC-MS identity data appear together on a COA and what each confirms
• What Research Use Only Means — what RUO designation means for documentation, handling, and laboratory context
• Peptide COA Review Checklist — structured field-by-field checklist for reviewing COA documentation

All compounds supplied by Phase 1 Peptides are for laboratory research use only. Not for human consumption, not for veterinary use, and not intended to diagnose, treat, cure, or prevent any disease or condition.